US-based pharmaceutical company ILC Dover has opened a new facility in Lillington, North Carolina to offer pre-filled trusted-weight cGMP raw materials for the growing biomanufacturing market.
As a solutions provider for the expanding life sciences industry, ILC Dover continues to meet market demands by developing comprehensive solutions customised to customers' unique needs and end applications.
ILC Dover will strengthen its position as a solutions provider by offering customers the most efficient, safest, and economical solution
Adjacent to KSE Scientific's headquarters in Durham, NC, the company's most recent acquisition, the new 48,000 sqft Lillington site will offer a portfolio of cGMP raw materials and dry repack capabilities across three ISO 7 cleanroom suites.
This new capability follows a recent expansion project within the Durham production facility which now offers Water For Injection (WFI) produced by distillation, a key raw material for the biopharmaceutical and cell and gene therapy markets.
"As our customers focus on developing life-saving drugs and therapies, our teams are working to protect and streamline steps within these critical workflows," said Corey Walker, CEO of ILC Dover. "Now, ILC Dover will strengthen its position as a solutions provider by offering customers the most efficient, safest, and economical solution to integrate powder weighing, filling, and dispensing into workflows."
Used primarily for buffer and cell culture media preparations in biopharmaceutical processing, ILC Dover's cGMP raw materials with versatile packaging solutions eliminate risk and contamination to a customer's workflow and reduce costs. The company has started to fill and repack dry chemicals in Lillington with additional capabilities coming in early 2023.